Could a cancer drug tame sickle cell pain?
NCT ID NCT03997903
First seen Feb 01, 2026 · Last updated May 16, 2026 · Updated 16 times
Summary
This early-phase study tested the drug imatinib in 7 people with sickle cell anemia who have frequent pain crises. The goal was to see if imatinib could reduce harmful changes in red blood cells and lower the number of severe pain episodes. The study was stopped early, so results are limited, but it aimed to find a new way to manage sickle cell pain without a cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cincinnati Children's Hospital
Cincinnati, Ohio, 45229, United States
-
Riley Hospital for Children at IU Health
Indianapolis, Indiana, 46202, United States
Conditions
Explore the condition pages connected to this study.